Clinical Trials Logo

Infertility, Male clinical trials

View clinical trials related to Infertility, Male.

Filter by:

NCT ID: NCT05866484 Active, not recruiting - Infertility, Male Clinical Trials

Testicular Sperm Aspiration (TESA) vs. Microfluidic Sperm Separation (MSS)

TESA vs Zymot
Start date: May 10, 2023
Phase:
Study type: Observational

Normal embryonic development relies on the correct transmission of genetic information, and sperm DNA plays a crucial part in this process. Causes of poor sperm DNA integrity include unhealthy lifestyles such as smoking and exposure to gonadotoxins, as well as, obesity, varicoceles, infections, advanced paternal age and systemic disorders. An increase in DNA fragmentation in sperm has been linked to lower fertilisation rate, poorer quality embryos, lower pregnancy rate, and high miscarriages rate. The best way for sperm selection and processing in assisted reproductive technologies (ART) should be noninvasive and cost-effective. It should also make it possible to identify high-quality spermatozoa and produce more favorable results in terms of pregnancy and live birth rates.7 Meanwhile, the microfluidic sperm separation technology is a less expensive and less invasive alternative. This method allows for the selection of motile sperm that have a normal morphology, low levels of reactive oxygen species (ROS), and low DFI

NCT ID: NCT05847257 Completed - Infertility, Male Clinical Trials

Impact of Co Enzyme Q10 as Adjuvant Therapy to Letrozole on Spermiogram

Start date: December 1, 2021
Phase: Phase 2
Study type: Interventional

Worldwide infertility affects about 15 % of reproductive-age couples. In many cases, infertility can't be treated, new treatment options with promising value were involved in the recent clinical trials.

NCT ID: NCT05846256 Recruiting - Infertility, Male Clinical Trials

Single and Double DNA Strand Breaks in Males With Unexplained Infertility Attending Fertility Treatment

Start date: April 25, 2023
Phase:
Study type: Observational

The aim of this study is to investigate the extent of double-stranded DNA damage in sperm in men with unexplained infertility.

NCT ID: NCT05792813 Not yet recruiting - Male Infertility Clinical Trials

Efficacy and Safety of Linggui Yangyuan Paste in Patients With Male Infertility

Start date: June 2023
Phase: Early Phase 1
Study type: Interventional

Male infertility affects millions of males worldwide and is rising in prevalence due to social and environmental conditions. Asthenozoospermia (AZS) and oligoasthenozoospermia (OA) are the major causes of male infertility. The diagnosis of male infertility has a negative effect on men's physical and psychological status, poses a threat to their social relationships, lowers self-esteem, and disrupts family harmony. At present, the treatment of ASZ and OA are all mostly empirical, including antioxidants, endocrine therapy, and anti-infection. However, there are still limitations due to inefficiencies. Linggui Yangyuan paste (LGYY), a traditional Chinese compound herbal past, had been used to treat ASZ and OA for several years at the Xiyuan Hospital of China Academy of Chinese Medical Sciences. The investigators designed this program to study the efficacy and safety of LGYY for the treatment of patients with male infertility (AZS and OA).

NCT ID: NCT05724979 Completed - Infertility, Male Clinical Trials

Outcome of Using Sperm Bound to the Zona Pellucida of Immature Oocytes for Intracytoplasmic Sperm Injection (ICSI)

Start date: March 5, 2021
Phase: N/A
Study type: Interventional

In vivo, the zona pellucida (ZP) of the oocyte can bind to normally functional sperm. The ZP-sperm interaction is one of the final steps of natural selection during their journey in the female reproductive tract. In the current study, we evaluated the ability of the ZP of immature oocytes to harvest the fittest sperm. We compared the embryological outcomes of intracytoplasmic sperm injection (ICSI) using conventionally selected sperm (control group) and ZP-bound sperm (intervention group). Our results showed no statistically significant superiority for the ZP binding technique over the conventional sperm selection with respect to the rates of fertilization and cleavage. However; the rates of blastocyst formation and high-quality blastocysts were significantly improved in the intervention group compare to the control group. These findings imply that the proposed technique can serve as a cost-effective and natural sperm selection method that has the potential to enhance the embryological and clinical outcomes of intracytoplasmic sperm injection (ICSI).

NCT ID: NCT05701163 Recruiting - Infertility, Male Clinical Trials

Assessing the Effect of Abstinence Period on Semen Parameters

Start date: April 4, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to learn about the impact of abstinence periods on sperm quality in healthy males 20-45 years of age with no significant comorbidities who are able to produce a semen sample via masturbation. The main question it aims to answer is: • Do shorter abstinence periods result in improved semen quality? Participants will provide semen samples for analysis following abstinence periods of 7 days, 5 days, 2 days, 1 day, and 3 hours.

NCT ID: NCT05628987 Recruiting - Infertility, Male Clinical Trials

The Association of Gut Microbiota and Spermatogenic Dysfunction

Start date: February 20, 2023
Phase:
Study type: Observational

This is a multicenter, case-control study that aims to investigate the relationship between microbiota and sperm quality via stool, blood, and urine microbiome, metabolomics, and collected clinical metadata. The results of the spermatogenic dysfunction, including aspermia, oligozoospermia, asthenozoospermia, and teratozoospermia, will be compared to normal basic semen analysis utilizing the World Health Organization (WHO) semen analysis procedure 5th edition.

NCT ID: NCT05616598 Completed - Male Infertility Clinical Trials

Effect of New Oral Treatment for Hepatitis C Virus on Seminal Parameters

Start date: March 1, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

Hepatitis C virus is commona viral infection. Direct-acting antiviral (DAA) oral drugs has been used in treatment of HCVs. the effect of these drugs on male infertility is still under investigation.

NCT ID: NCT05597631 Not yet recruiting - Infertility, Male Clinical Trials

G-IVF and Sperm Parameters

Start date: October 2023
Phase: N/A
Study type: Interventional

The aim of this study is to investigate if adding a fixed volume of a physiological solution to a freshly produced sperm sample will affect sperm characteristics.

NCT ID: NCT05514223 Not yet recruiting - Infertility Clinical Trials

Measuring Free Radicals in Human Sperm Cells Related to Microbiota and Lifestyle Factors

SIRIUS
Start date: March 1, 2024
Phase:
Study type: Observational

The cause of infertility can be due to a female factor or a male factor. In case of a male factor, it is often due to poor semen quality. However, the cause of poor quality is often unknown. In previous research, infertility problems in men were related to chemical processes in metabolism causing the formation of free radicals. Free radicals are physiological by-products of our body mechanisms. Free radicals are very reactive and can therefore react with a lot of molecules of cells within our body and cause damage. A balance between free radicals, which are also needed for physiological processes in the body, and antioxidants, which defuses the reactive free radicals, is most desirable. However, as stated in literature, there are a lot of factors that can influence extra free radical production, which causes overloading of the system, resulting in damage on cellular level. Free radicals in semen plasma and on the sperm cell could play a role in male infertility. Nonetheless, free radicals are not used as diagnostic markers due to the lack of detection systems, as free radicals are very short-lived. This study aims to introduce a new technique, called diamond magnetometry, to measure free radicals directly on the sperm cell and in serum. Diamond magnetometry involves very small diamond particles as magnetic sensors that engage a reaction with the free radicals on the sperm cell, causing signals that can be measured. To compare local free radical production with systemic free radical production, other diagnostic biomarkers are also measured in serum. It is hypothesized that the composition of seminal microbiome could influence the free radical concentration. Therefore, this study also aims to explore the microbiota composition and see if this has an influence in semen quality and free radical production. At last, this study also want to correlate standard semen parameters (defined by the World Health Organisation), lifestyle factors and food intake, to detect a role for lifestyle in the production of free radicals.